Abstract
Replication competent vesicular stomatitis virus (VSV) is the basis of a vaccine against Ebola and VSV strains are developed as oncolytic viruses. Both functions depend on the ability of VSV to induce adequate amounts of interferon-α/β. It is therefore important to understand how VSV triggers interferon responses. VSV activates innate immunity via retinoic acid-inducible gene I (RIG-I), a sensor for viral RNA. Our results show that VSV needs to replicate for a robust interferon response. Analysis of RIG-I-associated RNA identified a copy-back defective-interfering (DI) genome and full-length viral genomes as main trigger of RIG-I. VSV stocks depleted of DI genomes lost most of their interferon-stimulating activity. The remaining full-length genome and leader-N-read-through sequences, however, still triggered RIG-I. Awareness for DI genomes as trigger of innate immune responses will help to standardize DI genome content and to purposefully deplete or use DI genomes as natural adjuvants in VSV-based therapeutics.
Dokumententyp: | Zeitschriftenartikel |
---|---|
Keywords: | Vesicular stomatitis virus (VSV); retinoid acid inducible gene I (RIG-I); pattern recognition receptor (PRR); pathogen associated molecular pattern (PAMP); nucleic acid sensing; defective interfering genome |
Fakultät: | Medizin |
Themengebiete: | 600 Technik, Medizin, angewandte Wissenschaften > 610 Medizin und Gesundheit |
URN: | urn:nbn:de:bvb:19-epub-100141-4 |
ISSN: | 1664-3224 |
Sprache: | Englisch |
Dokumenten ID: | 100141 |
Datum der Veröffentlichung auf Open Access LMU: | 05. Jun. 2023, 15:34 |
Letzte Änderungen: | 28. Nov. 2023, 14:59 |